DUBLIN, May 22, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) approval for the Android™ version of ...

Medtronic plcMDT announced the receipt of FDA approval for the Guardian Connect continuous glucose monitoring (CGM) system for diabetes patients between the ages of 14 to 75 years. Notably, the system ...

Shortly after acquiring smart insulin-pen-maker Companion Medical, Medtronic has officially launched the InPen device alongside integration with its Guardian Connect connected glucose monitoring (CGM) ...

A continuous glucose monitor (CGM) is a small wearable device that sends blood sugar measurements directly to your smartphone or to a dedicated receiver device every few minutes. It offers people with ...

* SAYS ‍GUARDIAN CONNECT SYSTEM WILL BE AVAILABLE IN Q1 OF CO'S FISCAL YEAR 2019 Source text for Eikon: Further company coverage: ...

Please provide your email address to receive an email when new articles are posted on . McKee and colleagues conducted a retrospective survey of adults attending the Washington ...

Diagnostic device and digital healthcare companies are increasingly entering the continuous glucose monitoring (CGM) market, which allows real-time blood glucose measurement through sensors attached ...